Advertisement

Topics

Teva And Celltrion Say FDA Accepts BLA For Proposed Biosimilar To Rituxan

09:00 EDT 29 Jun 2017 | FinanzNachrichten

PETAH TIKVA (dpa-AFX) - Celltrion Inc., a global biopharmaceutical company, and Teva Pharmaceutical Industries Ltd. (TEVA) announced that the U.S. Food and Drug Administration has accepted for rev...

Original Article: Teva And Celltrion Say FDA Accepts BLA For Proposed Biosimilar To Rituxan

NEXT ARTICLE

More From BioPortfolio on "Teva And Celltrion Say FDA Accepts BLA For Proposed Biosimilar To Rituxan"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...